Mini Review
Published on 25 Apr 2024
The combination therapy of oncolytic virotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1380313
- 3,563 views
- 4 citations
Type at least 3 characters
2,300 articles
Review
Published on 25 Apr 2024
Black phosphorus, an advanced versatile nanoparticles of antitumor, antibacterial and bone regeneration for OS therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1396975
- 2,905 views
- 2 citations
Original Research
Published on 24 Apr 2024
Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1363511
- 3,671 views
- 10 citations
Mini Review
Published on 24 Apr 2024
The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395156
- 2,479 views
- 1 citation
Opinion
Published on 23 Apr 2024
Direct antitumor activity of bevacizumab: an overlooked mechanism?
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394878
- 3,776 views
- 3 citations
Review
Published on 22 Apr 2024
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1398419
- 4,522 views
- 7 citations
Original Research
Published on 22 Apr 2024
Role and mechanism of NCAPD3 in promoting malignant behaviors in gastric cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1341039
- 3,275 views
- 5 citations
Review
Published on 22 Apr 2024
Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1402514
- 4,118 views
- 6 citations
Editorial
Published on 18 Apr 2024
Editorial: New strategies for reversing cancer therapy resistance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411519
- 1,173 views
Original Research
Published on 18 Apr 2024
The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1390615
- 3,151 views
- 1 citation
Correction
Published on 18 Apr 2024
Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1363218
- 1,080 views
Systematic Review
Published on 17 Apr 2024
Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1322473
- 3,002 views
- 1 citation
Original Research
Published on 17 Apr 2024
Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1346719
- 2,768 views
- 3 citations
Review
Published on 16 Apr 2024
The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376955
- 2,158 views
Review
Published on 12 Apr 2024
Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1383580
- 2,731 views
- 2 citations
Review
Published on 12 Apr 2024
Research progress and applications of epigenetic biomarkers in cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1308309
- 4,098 views
- 5 citations